XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 35,449,563 $ 48,251,336
Marketable Securities 12,598,400 0
Accounts receivable 5,609,021 8,910,975
Prepaid and other current assets 2,446,768 1,936,842
Total current assets 56,103,752 59,099,153
Other assets    
Marketable Securities 2,500,675 0
Property and equipment - net 140,061 171,190
Right of use assets - operating leases 146,145 278,455
Patents and patent applications - net 12,657 13,000
Other non-current assets 0 1,051,234
Total assets 58,903,290 60,613,032
Current liabilities    
Accounts payable and accrued expenses 3,680,244 2,966,479
Accrued salaries and wages 480,929 908,516
Royalty payable 979,489 1,908,072
Deferred revenue 859,315 354,756
Operating leases 148,623 282,421
Total current liabilities 6,148,600 6,420,244
Long-term liabilities    
License Fee Payable, Noncurrent 18,768,938 18,700,546
Total long-term liabilities 18,768,938 18,700,546
Total liabilities 24,917,538 25,120,790
Stockholders' equity    
Common stock; par value $0.001; 200,000,000 shares authorized; 4,330,594 and 4,258,105 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 4,331 4,259
Additional paid-in capital 101,529,146 100,203,979
Accumulated other comprehensive loss (14,430) (26,931)
Accumulated deficit (67,533,295) (64,689,065)
Total stockholders' equity 33,985,752 35,492,242
Total liabilities and stockholders' equity $ 58,903,290 $ 60,613,032